Home  /  Resource Library  /  Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

Study performed an indirect comparision between zanubrutinib and orelabrutinib for treatment of relapsed MCL.